Phase II study of everolimus (RAD001) monotherapy as first-line treatment in advanced biliary tract cancer with biomarker exploration: the RADiChol Study.
British journal of cancer 2018 Mar .
Lau David K, Tay Rebecca Y, Yeung Yvonne H, Chionh Fiona, Mooi Jennifer, Murone Carmel, Skrinos Effie, Price Timothy J, Mariadason John M, Tebbutt Niall
- Page last reviewed:Mar 1, 2018
- Page last updated:Jul 18, 2019
- Content source: